Skip to main content
TDSPHARM Co., Ltd. logo

TDSPHARM Co., Ltd. — Investor Relations & Filings

Ticker · 464280 ISIN · KR7464280007 KO Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2025-09-02 Major Shareholding Noti…
Country KR South Korea
Listing KO 464280

About TDSPHARM Co., Ltd.

http://tdspharm.gobizkorea.com/

TDSPHARM Co., Ltd. is a pharmaceutical company specializing in the research, development, and manufacturing of Transdermal Drug Delivery Systems (TDDS), where active ingredients are absorbed through the skin. The company focuses on creating safe and effective medicinal products through dedicated R&D efforts. Its product portfolio includes a variety of TDDS-based items such as medical cataplasmas, plasters, and patches for applications like pain relief and antibiotic delivery. In addition to its core pharmaceutical business, TDSPHARM also develops and manufactures Over-The-Counter (OTC) medicines and cosmetic products, aiming to provide a wide selection of accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Kim Chuljun) and special related parties in the company 'TDS Pharm'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-09-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a transaction (purchase of 2,000 shares) by a director/major shareholder (Kim Chul-jun) of TDS Pharm. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2025-09-02 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 티디에스팜' (TDS PHARM Co., Ltd.) covering the period from 2025-01-01 to 2025-06-30. It contains detailed financial information, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'TDS PHARM Co., Ltd.' (주식회사 티디에스팜) covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial data, business operations, and management analysis, which is characteristic of an interim/quarterly financial report. It is not a mere announcement or certification, as it includes substantive financial statements and operational details. Q1 2025
2025-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose changes in their shareholdings (insider trading). Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2025-05-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (Kim Chuljun and special related parties) of TDS Pharm. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2025-05-02 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.